Thomas Dupont-Sentilles

Thomas Dupont-Sentilles is a partner in Goodwin’s Technology and Life Sciences groups and advises the full range of investors and companies seeking venture capital investment in France and cross-border.

He also advises European and US clients on a broad range of corporate law matters, including domestic and cross-border M&A, private equity deals and leveraged buyouts, and management incentive schemes.

Thomas also undertakes corporate and commercial advisory work for a broad range of corporate clients and private equity portfolio companies.

Prior to joining Goodwin in 2016, Thomas was a senior associate in the corporate and private equity team of King & Wood Mallesons LLP (formerly SJ Berwin) for 10 years. In 2007, he spent some time in SJ Berwin’s London office.

Thomas’s recent transactions include advising:

Venture Capital / Growth Equity

• A confidential investor in the $600 million Series B financing of Mistral AI, a French-based company developing an AI-powered data entry system for companies.
• Exor Ventures:
  • in the €9.2 million Series Seed financing of Zeliq, a company specialized in the development and the commercialization of solution that gives to its customers the most accurate prospect data.
  • in its investment in the €15 million Series A financing of Inbolt, a Parisian startup specialized in the development and the commercialization of real-time industrial robot vision and guidance system based on 3D Vision and AI.
• Fidelity International Strategic Ventures in the $52 million Series B financing of Greenly, a carbon accounting & management platform for SMEs, helping businesses track and measure their carbon emissions in order to accelerate their transition to a net-zero carbon economy.
• Lead Edge Capital in the €12 million Series A extension financing of Yousign, an e-signature provider that complies with European regulation on digital signatures.
• One Peak in the €107.8 million Series C financing of Akur8, a machine learning-powered insurance pricing and reserving platform.
• SpinEM Robotics, a company developing a next generation tracking solution for robotic spinal surgery, in its €10 million Series A2 financing.
• UroMems, a French company developing innovative implantable medical devices and notably specialized in treating Stress Urinary Incontinence, in its €44 million Series C financing.

LBO and Other Transactions

• Arcole in the acquisition of Babel, a communication agency.
• The management of Ipackchem, a global market leader in the production of high-performance plastic packaging, in the sale of the group to Greif.
• LFPI in the acquisition of a minority stake of Montaner Pietrini Boissons, a top-selling independent French distributor of beverages to cafés, hotels, and restaurants, alongside the founders.
• The sellers in the sale of BeReal, a photo sharing application that allows users to post one photo per day to show their followers what they are doing in real time, to Voodoo.
• Scottish Equity Partners in their investment in Braincube, a French manufacturing data software company.
• Yassir, an Algeria-based delivery app operating in the Middle East, in the acquisition of Flink, a food delivery services provider.

Thomas is consistently recognized as a leader in his field by International and French preeminent, peer-reviewed publications:

• Ranked as Next Generation Partner in Private Equity: Venture/Growth Capital in the last edition of the Legal 500 EMEA guide
• Ranked in Band 3 in Private Equity: Venture Capital in the last edition of the Chambers Europe guide
• Recommended in Venture Capital Law in the last edition of Best Lawyers France

Author, “Startuppers en 2025 : Comment naviguer en eaux troubles," Maddyness, January 2025